<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03538392</url>
  </required_header>
  <id_info>
    <org_study_id>Serranator® Alto PMCF Study</org_study_id>
    <nct_id>NCT03538392</nct_id>
  </id_info>
  <brief_title>Serranator® Alto Post Market Clinical Follow Up (PMCF) Study</brief_title>
  <official_title>Post Market Clinical Follow-up Study - PMCF Study, Serranator® Alto</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cagent Vascular LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cagent Vascular LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this registry is to collect observational data under local standard of care
      and evaluate safety and performance of the Serranator® Alto in treatment of peripheral artery
      disease (PAD), or dysfunctional native or synthetic arteriovenous dialysis fistulae in a
      real-world scenario.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single Arm, multi-center, device registry study capturing de-identified data on a minimum of
      100 subjects with peripheral artery disease (PAD) and/or dysfunctional native or synthetic
      arteriovenous dialysis fistulae. The study will capture acute angiographic data.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Performance</measure>
    <time_frame>The registry will collect acute procedural data through hospital discharge, no additional follow up is required. Performance data will be summarized after enrollment is complete, estimated to be 1 year.</time_frame>
    <description>Device Success defined as the achievement of successful delivery, balloon inflation and deflation, and retrieval of the study device(s) with a diameter stenosis of &lt;50% by visual assessment at the intended target site after using the Serranator® device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Collection of device related Major Adverse Events (MAE) until discharge</measure>
    <time_frame>Within 12-24 hours post-procedure or prior to hospital discharge, whichever occurs first</time_frame>
    <description>Safety defined as incidence of device related MAE, defined as amputations or re-interventions (surgical or endovascular)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Arterio-venous Fistula</condition>
  <condition>Arteriovenous Graft</condition>
  <arm_group>
    <arm_group_label>PAD</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>AV Fistula</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>AV Graft</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Serranator® Alto</intervention_name>
    <description>Serranator® Alto PTA Serration Balloon Catheter</description>
    <arm_group_label>PAD</arm_group_label>
    <arm_group_label>AV Fistula</arm_group_label>
    <arm_group_label>AV Graft</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of subjects with claudication or ischemic rest pain,
        requiring dilatation of lesions, in the iliac or femoropopliteal arteries, or dysfunctional
        native or synthetic arteriovenous dialysis fistulae.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  Subject requires angioplasty

          -  Subject has a lesion in the iliac, femoral, iliofemoral, popliteal artery, or
             obstructive lesion of native or synthetic arteriovenous dialysis fistulae as per the
             product indications for use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Audrey Sahns</last_name>
    <phone>610-688-2006</phone>
    <email>asahns@cagentvascular.com</email>
  </overall_contact>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2018</study_first_submitted>
  <study_first_submitted_qc>May 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2018</study_first_posted>
  <last_update_submitted>May 24, 2018</last_update_submitted>
  <last_update_submitted_qc>May 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

